Drug intelligence / Profile preview

Kecuo Yintong Gel

Development stage: Unknown
Lead developer: Hefei Lifeon Pharmaceutical
Modality: Small Molecules
Administration: Topical

Overview

Kecuo Yintong Gel is an approved topical fixed-dose anti-acne gel developed and manufactured by Hefei Lifeon Pharmaceutical. The formulation contains tanshinone powder, trimethoprim, vitamin A, and vitamin E. It is indicated for blackhead and whitehead comedones and is described as suppressing sebaceous-gland secretion and inhibiting acne-associated bacterial growth; its individual molecular targets have not been publicly specified. ([lifeonapi.com](https://www.lifeonapi.com/productfdf.php?catid=5&sec_id=29))

Other names: 克痤隐酮凝胶

Beyond the preview

Go deeper on Kecuo Yintong Gel.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

Trial phase
Status
Readouts

Indications & development

Explore development by indication, patient population, and geography.

Indications
Development status
Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

Partners
Deal terms
Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

Patents
Expiration dates
Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

Competing assets
Targets
Development stage

Research & analysis

Connect source evidence and development news to your research questions.

Publications
News
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Kecuo Yintong Gel.

Explore the full profile